Calidi Biotherapeutics: Funding, Investors & Team (Oct 2026)
Calidi Biotherapeutics is a company specializing in developing immunotherapies using oncolytic viruses to treat challenging cancers. The company's patented technology enables targeted delivery of these viruses, providing healthcare professionals with cutting-edge cancer treatment options.
Calidi Biotherapeutics has raised $45.1M across 8 funding rounds on record, the most recent an undisclosed round of $4.6M announced in Jul 2025.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Calidi Biotherapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2025.
Calidi Biotherapeutics Funding Rounds
Calidi Biotherapeutics raised $3.1M in an undisclosed round announced in Dec 2022.
6 months later, a Series B of $25.0M was announced in Jun 2023.
3 months later, an undisclosed round of $2.0M was announced in Sep 2023.
6 months later, an undisclosed round of $200k was announced in Mar 2024.
7 months later, an undisclosed round of $2.0M was announced in Oct 2024.
3 months later, an undisclosed round of $4.3M was announced in Jan 2025.
2 months later, an undisclosed round of $3.9M was announced in Mar 2025.
4 months later, an undisclosed round of $4.6M was announced in Jul 2025.
Calidi Biotherapeutics Founders and Leadership Team
Contact details for the Calidi Biotherapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Calidi Biotherapeutics Funding Compared to Other Biotechnology Startups
Calidi Biotherapeutics' latest round of $4.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Calidi Biotherapeutics in Biotechnology and San Diego
Companies Similar to Calidi Biotherapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Calidi Biotherapeutics Funding FAQs
What does Calidi Biotherapeutics do?
Calidi Biotherapeutics is a company specializing in developing immunotherapies using oncolytic viruses to treat challenging cancers. The company's patented technology enables targeted delivery of these viruses, providing healthcare professionals with cutting-edge cancer treatment options.
How much funding has Calidi Biotherapeutics raised?
Calidi Biotherapeutics has raised $45.1M across 8 rounds on record. The most recent is an undisclosed round of $4.6M announced in Jul 2025.
When did Calidi Biotherapeutics last raise funding?
Calidi Biotherapeutics' most recent funding round on record is an undisclosed round of $4.6M, announced in Jul 2025.
Who founded Calidi Biotherapeutics?
FundedIQ lists Allan Camaisa (Founder) at Calidi Biotherapeutics.
Where is Calidi Biotherapeutics headquartered?
Calidi Biotherapeutics is based in San Diego, California, United States.
How many employees does Calidi Biotherapeutics have?
Calidi Biotherapeutics is in the 11-50 employee band.
How does Calidi Biotherapeutics' funding compare to other Biotechnology startups?
Calidi Biotherapeutics' latest round of $4.6M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Calidi Biotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Calidi Biotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.